高阶指令市场：现况分析与预测（2023-2030）

Advance Directives Market: Current Analysis and Forecast (2023-2030)

出版日期: 2024年01月30日 | 出版商:

UnivDatos Market Insights Pvt Ltd | 英文 148 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录

由于老年人口的增加，预计高级指令市场在预测期内将以 18.1% 的复合年增长率强劲增长。例如，根据美国人口普查局的数据，到 2050 年，全球 65 岁及以上人口预计将达到 16 亿，是 2018 年这一数字的两倍多。同样，世界卫生组织 (WHO) 估计，到 2050 年，60 岁及以上的人口数量将从 2017 年的 9.62 亿增加近两倍，达到 21 亿。这些统计数据表明，世界各地的老年人口正在显着增加。传播对这些设施的认识非常重要，因为它们尊重个人的意愿并赋予他们在医疗方面拥有发言权的权力。这种意识有助于人们为突发事件做好计划，并促进医疗保健决策的自主性和尊严。对高级医疗指示的认识不断提高以及慢性病患者数量的迅速增加正在推动高级医疗指示市场的发展。

根据组件，市场分为服务和软体。到 2022 年，服务业将占据市场的大部分份额，因为这些服务提供的文件很容易。服务包括制定全面的临终计划，考虑医疗、情感和精神方面，并帮助您向家人和医疗保健提供者传达您的愿望。服务部门在促进深思熟虑和有效实施预立指示以及确保个人的医疗保健偏好得到倾听和尊重方面发挥关键作用。因此，在2022年的预测期内，服务业占据市场的大部分份额。

根据人口统计数据，市场分为 50 岁以上、35-49 岁和 34 岁及以下。预计 35 岁以上但 49 岁以下的细分市场将在预测期内在市场上占据主导地位。 35岁至49岁的市场细分涵盖了广泛的年龄范围，弥合了年轻人和老年人之间的差距。高级医疗指示市场中中年人的特征是对医疗保健规划重要性的认识不断增强。 35 岁至 49 岁的人通常会考虑制定预先指示，例如生前预嘱或持久授权书，以概述他们的医疗保健偏好并指定某人代表他们做出决定。这一市场趋势是由人口老化、对患者自主权的重视以及对主动医疗保健规划好处的认识所推动的。因此，35-49 岁年龄层预计将在预测期内在市场上占据主导地位。

为了更了解罕见血友病因子产业的市场介绍，将市场分为北美（美国、加拿大、北美其他地区）、欧洲（德国、英国、法国、西班牙、义大利、欧洲其他地区）），亚太地区根据全球分布（中国、日本、印度、亚太地区其他地区）和世界其他国家进行分析。 2022 年，北美主导罕见血友病因子市场。有几个因素正在增加对高级指令的需求，例如创新软体的可用性、高级指令意识的提高以及该地区老年人口的增加，从而推动了该地区的市场。北美在2022年各地区罕见血友病因子市场中占据主导地位。

市场上营运的主要公司包括 ADvault, Inc.、WiserCare、Sharp HealthCare、ACP Decisions（Nous Foundation, Inc. 的 DBA）、Iris、Bronson Health Care Group, Inc.、ThoroughCare, Inc.、Vital Decisions LLC 、New Century Health 和Island Health。

Advance directives are legal documents that allow individuals to specify their healthcare preferences and decisions in advance, particularly in situations where they may be unable to communicate or make decisions for themselves. These documents guide healthcare professionals and family members regarding the person's wishes for medical treatment. As the global population ages, the incidence of chronic disorders is expected to rise, thus fueling the demand for end-of-life care options. Additionally, technological advancements in the software have improved the usage and efficiency of advance directive software, further driving market growth. Studies have found that aging patients encounter problems typical of old age compounded by dementia, which is driving the market globally.

The Advance Directives Market is expected to grow at a strong CAGR of 18.1% during the forecast period owing to the rising geriatric population. For instance, according to the U.S. Census Bureau, the global population aged 65 and older is projected to reach 1.6 billion by 2050, more than double the population in 2018. Similarly, the World Health Organization (WHO) estimates that the number of people aged 60 and above will nearly triple by 2050, from 962 million in 2017 to 2.1 billion. These statistics indicate a significant increase in the geriatric population worldwide. Spreading awareness about such facilities is very crucial as it empowers individuals to have a say in their medical treatment, ensuring their wishes are respected. This awareness helps people plan for unforeseen circumstances, promoting autonomy and dignity in healthcare decisions. The rising awareness about advance directives and the surge in chronic disease cases are driving the advance directives market.

Based on components, the market is bifurcated into services and software. The services segment held the majority share of the market in 2022 because of the ease of documentation provided by these services. Under services, assistance is provided in developing comprehensive end-of-life plans, considering medical, emotional, and spiritual aspects, and helping individuals communicate their preferences to family members and healthcare providers. The services segment plays a crucial role in facilitating the thoughtful and effective implementation of advance directives, ensuring that individuals' healthcare preferences are communicated and respected. Hence, the service category held the majority share of the market in the year 2022 during the forecast period.

Based on demographics, the market is segmented into above 50 years, 35 to 49 years, and below 34 years. The above 35 to 49 years segment is expected to gain prominence in the market in the forecast period. The 35 to 49 years segment in the advance directives market encompasses a broad age range of individuals bridging the gap between young adults and the geriatric population. The middle-aged population's status in the advance directives market was generally characterized by a growing awareness of the importance of healthcare planning. 35 to 49 years individuals often consider creating advance directives, such as living wills and durable power of attorney, to outline their medical preferences and designate someone to make decisions on their behalf. This market trend is driven by an aging population, increased emphasis on patient autonomy, and the recognition of the benefits of proactive healthcare planning. Thus, the 35 to 49 years segment is expected to gain prominence in the market in the forecast period.

For a better understanding of the market adoption of the rare hemophilia factors industry, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America dominated the market of rare hemophilia factors in 2022. Several factors such as the availability of innovative software, growing awareness of advance directives, and the rising geriatric population in the region are increasing the demand for advance directives, which are driving the market in the region. North America dominated the rare hemophilia factors market among regions in the year 2022.

Some of the major players operating in the market include ADvault, Inc.; WiserCare; Sharp HealthCare; ACP Decisions (a DBA of Nous Foundation, Inc.); Iris; Bronson Health Care Group, Inc.; ThoroughCare, Inc.; Vital Decisions LLC; New Century Health; Island Health.

1 MARKET INTRODUCTION

1.1. Market Definitions
1.2. Main Objective
1.3. Stakeholders
1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1. Research Process of the Advance Directives Market
2.2. Research Methodology of the Advance Directives Market
2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE ADVANCE DIRECTIVES MARKET

6 ADVANCE DIRECTIVES MARKET REVENUE (USD BN), 2020-2030F

7 MARKET INSIGHTS BY COMPONENT

7.1. Services
7.2. Software

8 MARKET INSIGHTS BY DEMOGRAPHICS

8.1. Above 50 years
8.2. 35 to 49 years
8.3. Below 34 years

9 MARKET INSIGHTS BY REGION

9.1. North America
- 9.1.1. U.S.
- 9.1.2. Canada
- 9.1.3. Rest of North America
9.2. Europe
- 9.2.1. Germany
- 9.2.2. U.K.
- 9.2.3. France
- 9.2.4. Italy
- 9.2.5. Spain
- 9.2.6. Rest of Europe
9.3. Asia-Pacific
- 9.3.1. China
- 9.3.2. Japan
- 9.3.3. India
- 9.3.4. Rest of Asia-Pacific
9.4. Rest of World